Share
Single-use Bioprocessing Market Size, Share, and Analysis, By Product (Filtration Assemblies, Disposable Bioreactors, Disposable Mixers, Media Bags & Containers, and Others), By Application (Filtration, Purification, Cell Culture, Mixing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, CMOs & CROs), By Workflow (Upstream, Downstream, Fermentation) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034 Â
Single-use Bioprocessing Market, valued at USD 28.8 billion in 2023, is expected to expand at a compound annual growth rate (CAGR) of 16.5% over the forecast period from 2024 to 2034, reaching an estimated market size of USD 154.4 billion by 2034.
Single-use bioprocessing involves the use of disposable, pre-sterilized equipment and components for manufacturing biopharmaceutical products. This technology offers significant benefits, such as cost reduction by eliminating the need for cleaning and sterilization between batches, resulting in lower operational costs and reduced downtime. Single-use systems also provide increased flexibility, allowing for easy scaling of production processes to meet changing demands. They help minimize the risk of cross-contamination, enhancing product safety. The rapid setup and processing times associated with disposable equipment accelerate the development and production cycle, leading to a faster time-to-market. The growing demand for biopharmaceuticals is driving the adoption of single-use bioprocessing among biotech and pharmaceutical companies, as well as contract research and manufacturing organizations.
Single-use Bioprocessing Market is expected to achieve a value of USD 154.4 billion, with a growth rate of 16.5% over the forecast period. The market growth is driven by the cost-effectiveness, operational flexibility, and enhanced product safety offered by single-use systems. The elimination of cleaning and sterilization processes between batches reduces operational costs and downtime. The ability to quickly scale production processes is crucial for meeting the evolving needs of biopharmaceutical development. Moreover, single-use systems reduce the risk of contamination, ensuring product safety. The market is expected to continue growing due to the increasing demand for biopharmaceuticals, advancements in single-use materials and technologies, regulatory support, and the industry's shift towards more agile manufacturing processes.
Source: Fatpos Global
Single-use Bioprocessing Market is segmented based on Application into Filtration, Purification, Cell Culture, Mixing, and Others. is a critical aspect of single-use bioprocessing due to its essential role in biopharmaceutical production and diverse applications. It is crucial for both upstream and downstream processes, removing impurities and contaminants to ensure product purity. Filtration serves various purposes, including clarification, sterilization, depyrogenation, purification, and recovery. Technological advancements in membrane and depth filtration technologies have enhanced their effectiveness. Regulatory requirements also drive the need for advanced filtration systems to ensure compliance with safety standards. In bioprocessing, filtration is used for media sterilization, cell removal, clarification, capturing the product, impurity removal, and final product polishing. Cross-flow filtration is widely employed for protein solution concentration and diafiltration.
Single-use Bioprocessing Market into Workflow into Upstream, Downstream, and Fermentation. Upstream processing currently leads the single-use bioprocessing market due to its critical role in growing and multiplying cell cultures for biopharmaceutical manufacturing. This process requires a variety of consumables, including cell culture media, buffers, and other solutions, necessitating the use of disposable items such as bags, tubing, and bioreactors. During the initial stages of development, biopharmaceutical companies often conduct experiments with different cell lines and culture conditions, leading to frequent process changes and a greater reliance on disposable equipment. Single-use systems offer unparalleled scalability and flexibility in upstream processes, enabling quick adjustments in production volume and process parameters, making them ideal for dynamic and evolving bioprocessing needs.
Increased Demand and Adoption of Single-Use Systems to Drive Market Growth
Rising demand and adoption of single-use systems are expanding the single-use bioprocessing market. The increased productivity offered by these systems, due to reduced cleaning and sterilization times, leads to faster production cycles and higher output, which is crucial in the rapidly evolving biopharmaceutical sector. The disposable nature of single-use components reduces the risk of cross-contamination, ensuring the purity and safety of products in biologics manufacturing. Single-use systems also offer greater flexibility in process development and scale-up, easily adapting to different product formulations and production volumes. Additionally, they require less capital investment compared to traditional stainless steel equipment, making them attractive to smaller biotech firms and new market entrants.
Rising Investment in Research and Development Activities Are Fueling Market Expansion
Significant investments in research and development (R&D) are driving the growth of the single-use bioprocessing market. Advances in bioprocessing technologies are facilitating the development of new biologics, such as monoclonal antibodies and cell therapies. Single-use systems provide the necessary precision and flexibility for these complex processes. R&D efforts focus on improving efficiency, yield, and product quality through process optimization, leveraging single-use systems for rapid experimentation. Investing in R&D also fosters technological advancements, resulting in innovative single-use components and systems that expand the market's capabilities and applications. Moreover, disposable systems enable faster process development and scale-up, accelerating the time to market for new biopharmaceuticals.
Stringent Regulatory Laws to Create Challenges for Market Growth
Stringent regulatory laws pose a significant challenge to the growth of the single-use bioprocessing market. These regulations are designed to ensure product safety and efficacy, enforcing strict quality standards and compliance requirements. The complex validation processes for sterility, biocompatibility, and performance require significant time and resources, leading to delays in product launches and higher development costs. Smaller companies often struggle with understanding and complying with evolving regulations, necessitating substantial expertise and financial resources. Strict regulatory compliance also increases manufacturing costs due to extensive documentation, quality control procedures, and specialized personnel, reducing profitability. Regulatory constraints on materials can hinder innovation, and varying requirements across different countries add to the operational complexity and administrative burden. Despite these challenges, the industry continues to invest in robust quality control systems and measures to minimize risks and ensure regulatory compliance.
Single-use Bioprocessing Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America holds a dominant position in the single-use bioprocessing market attributed to various important reasons. The region boasts a significant number of top biopharmaceutical firms, fueling a substantial need for disposable systems. Having been quick to embrace these technologies, North America has cultivated a stable and advanced market. Substantial investments in research and development have promoted notable innovation in single-use bioprocessing. Moreover, a somewhat simplified regulatory landscape has also helped boost market expansion.
Source: Fatpos Global
Single-use bioprocessing market was significantly influenced by the COVID-19 pandemic, resulting in a mix of difficulties and benefits. At first, production was impacted by disruptions in the supply chain and temporary shortages of raw materials. Capacity limitations emerged due to increased demand, resulting in delays and bottlenecks. Nevertheless, the positive impact in the long run has been substantial. The quick demand for fast vaccine and treatment creation sped up the acceptance of single-use systems, valued for their flexibility, scalability, and decreased contamination danger. Greater funding in the biopharmaceutical sector and the growing need for vaccines and therapeutics continued to drive growth in the single-use market. The pandemic also drove technological progress in disposable technologies, solidifying their position as the top option for biopharmaceutical production and showcasing the sector's ability to bounce back and adjust.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2034 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2034 |
|
Historical Period |
2019-2022 |
|
Growth Rate |
CAGR of 16.5% from 2024-2034 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
By Product |
|
|
By Application |
|
|
By End User |
|
|
By Workflow |
|
|
By Region |
|
Single-use Bioprocessing Market size was valued at USD 28.8 billion in 2023 and is projected to reach USD 154.4 billion in 2034, exhibiting a CAGR of 16.5% during the forecast period.
The Single-use Bioprocessing Market encompasses disposable technologies and equipment used in biopharmaceutical manufacturing. It includes single-use bioreactors, filtration devices, chromatography columns, and other components designed for one-time use. This market caters to the growing demand for flexible, cost-effective, and contamination-reducing solutions in bioprocessing, particularly in the production of biologics and vaccines.
The Filtration and Upstream accounted for the largest Single-use Bioprocessing Market share.
Key players in the Single-use Bioprocessing Market include Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Sartorius AG, Merck KGaA, GE Healthcare, Eppendorf AG, Corning Incorporated, Saint-Gobain, Parker Hannifin Corporation, 3M, Meissner Filtration Products, Inc., CESCO Bioengineering Co., Ltd., Rentschler Biopharma SE, Entegris, Inc., Kuhner AG and Other Prominent Players.
Rising demand for biologics, increased focus on process efficiency, and growing emphasis on product safety drive the single-use bioprocessing market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
